A Phase 2 Study of Cusatuzumab Plus Azacitidine in Patients With Newly Diagnosed Acute Myeloid Leukemia Who Are Not Candidates for Intensive Chemotherapy

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT04023526

Title field or adapter rule

{'original_value': 'A Phase 2 Study of Cusatuzumab Plus Azacitidine in Patients With Newly Diagnosed Acute Myeloid Leukemia Who Are Not Candidates for Intensive Chemotherapy', 'source_field': 'protocolSection.identificationModule.officialTitle'}

Ingested At

2026-10-31T23:27:29.041508+00:00

Published At

2024-07-30T00:00:00+00:00

Record Updated At

2026-10-30

Results Posted At

2024-07-30

Source Retrieved At

2026-10-31T22:18:09.361634+00:00

Timestamp Basis

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Date limitation

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Leukemia, Myeloid, Acute"]

protocolSection.statusModule.lastUpdatePostDateStruct

{"date": "2026-10-30", "type": "ACTUAL"}

protocolSection.identificationModule.nctId

"NCT04023526"

protocolSection.identificationModule.officialTitle

"A Phase 2 Study of Cusatuzumab Plus Azacitidine in Patients With Newly Diagnosed Acute Myeloid Leukemia Who Are Not Candidates for Intensive Chemotherapy"

protocolSection.statusModule.overallStatus

"ACTIVE_NOT_RECRUITING"

protocolSection.designModule.phases

["PHASE2"]

protocolSection.statusModule.resultsFirstPostDateStruct

{"date": "2024-07-30", "type": "ACTUAL"}

Study condition terms

• Leukemia, Myeloid, Acute (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

• {'armGroupLabels': ['Azacitidine 75 mg/m^2 and Cusatuzumab 10 mg/kg', 'Azacitidine 75 mg/m^2 and Cusatuzumab 20 mg/kg'], 'description': 'Azacitidine SC or IV will be administered at a standard dose of 75 mg/m\\^2 on days 1-7 of each cycle.', 'name': 'Azacitidine', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Azacitidine 75 mg/m^2 and Cusatuzumab 10 mg/kg', 'Azacitidine 75 mg/m^2 and Cusatuzumab 20 mg/kg'], 'description': 'Cusatuzumab IV will be administered as 10 mg/kg or 20 mg/kg on days 3 and 17 of each cycle.', 'name': 'Cusatuzumab', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

• Azacitidine (protocolSection.armsInterventionsModule.interventions[].name)
• Cusatuzumab (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.